AstraZeneca and Oxford University: Confirms immune response in elderly, phase 3 vaccine trial results in weeks

AstraZeneca and Oxford University jointly developed COVID-19 vaccine-induced immune response in older adults in their phase 2 trial, the British drug makers confirmed Thursday.

Additional details

“AstraZeneca phase 2 study does not assess efficacy against COVID-19. “

“Results of phase 3 AstraZeneca vaccine trial expected in weeks.”

developing story ....